Oaktree Acquisition III Life Sciences Revenue 2025-2024 | OACC
Oaktree Acquisition III Life Sciences revenue from 2025 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Oaktree Acquisition III Life Sciences Annual Revenue (Millions of US $) |
|---|
| Oaktree Acquisition III Life Sciences Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aduro Clean Technologies (ADUR) | Canada | $0.179B | 0.00 |
| Tavia Acquisition (TAVI) | $0.138B | 0.00 | |
| Youxin Technology (YAAS) | $0.096B | 0.00 | |
| YSX Tech (YSXT) | $0.091B | 0.00 | |
| Leishen Energy Holding (LSE) | $0.087B | 0.00 | |
| YHN Acquisition I (YHNA) | $0.080B | 0.00 | |
| New Century Logistics (BVI) (NCEW) | $0.051B | 0.00 | |
| Sky Quarry (SKYQ) | $0.022B | 0.00 |